首頁 › 頭頸部鱗狀細胞癌 › 加州 › Baldwin Park
Baldwin Park, CA 的 頭頸部鱗狀細胞癌 臨床試驗
16 項針對 頭頸部鱗狀細胞癌 的研究正在 Baldwin Park（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- City of Hope National Medical Center, Duarte · 距離 4 英里
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- City of Hope National Medical Center, Duarte · 距離 4 英里
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
招募中2 期
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte · 距離 4 英里
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
招募中1 期
- Research Site, Duarte · 距離 4 英里
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
招募中3 期
- City of Hope, Duarte · 距離 4 英里
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
招募中1 期
- City of Hope, Duarte · 距離 4 英里
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- City of Hope Cancer Center, Duarte · 距離 4 英里
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
招募中1/2 期
- City of Hope, Duarte · 距離 4 英里
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
招募中觀察性研究
- City of Hope, Duarte · 距離 4 英里
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
招募中1 期
- City of Hope Comprehensive Cancer Center, Duarte · 距離 4 英里
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
招募中1 期
- City Of Hope Comprehensive Cancer Center /ID# 276550, Duarte · 距離 4 英里
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
招募中1/2 期
- City of Hope, Duarte · 距離 4 英里
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- City of Hope National Medical Center /ID# 276272, Duarte · 距離 4 英里
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
招募中2/3 期
- City of Hope National Medical Center, Duarte · 距離 4 英里
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
招募中1 期
- City of Hope, Duarte · 距離 4 英里
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
招募中3 期
- City of Hope, Duarte · 距離 4 英里
其他城市的 頭頸部鱗狀細胞癌 試驗
- Houston, TX47 項研究
- Los Angeles, CA42 項研究
- Boston, MA40 項研究
- Nashville, TN39 項研究
- New York City, NY39 項研究
- St. Louis, MO28 項研究
- Arlington, VA26 項研究
- Chicago, IL26 項研究
- Philadelphia, PA26 項研究
- Atlanta, GA24 項研究
- San Antonio, TX22 項研究
- Pittsburgh, PA22 項研究
Baldwin Park 的其他研究
- 乳癌44 項研究
- 急性髓系白血病40 項研究
- 大腸直腸癌37 項研究
- 非小細胞肺癌36 項研究
- 癌症（所有類型）34 項研究
- 前列腺癌30 項研究
- 轉移性癌症30 項研究
- 骨髓增生異常症候群26 項研究
- 卵巢癌25 項研究
- 肺癌24 項研究
- 多發性骨髓瘤23 項研究
- 胃癌22 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。